Systemic Therapy, Trials, and Future Directions for Chordoma of the Spine
- 23 July 2021
- book chapter
- other
- Published by Springer Science and Business Media LLC
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordomaThe Journal of Pathology, 2012
- Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and matrix metalloproteinase-2 in sacral chordomasOncology Letters, 2012
- Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature reviewBMC Cancer, 2011
- Frequent activation of EGFR in advanced chordomasClinical Sarcoma Research, 2011
- Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomasNeuro-Oncology, 2010
- Response to erlotinib in a patient with treatment refractory chordomaAnti-Cancer Drugs, 2009
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor SarcomasJournal of Clinical Oncology, 2009
- Chordoma and chondrosarcoma gene profile: implications for immunotherapyCancer Immunology, Immunotherapy, 2008
- Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationBritish Journal of Cancer, 2007
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000